News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
72,139 Results
Type
Article (1974)
Company Profile (2)
Press Release (70163)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (21545)
Career Advice (9)
Deals (4565)
Drug Development (8167)
FDA (1806)
Job Trends (806)
News (37104)
Policy (3562)
Tag
Academia (97)
Accelerated approval (2)
Allergies (15)
Alliances (8188)
ALS (12)
Alzheimer's disease (156)
Antibody-drug conjugate (ADC) (59)
Approvals (1909)
Artificial intelligence (27)
Autoimmune disease (10)
Automation (1)
Bankruptcy (8)
Best Places to Work (590)
BIOSECURE Act (1)
Biosimilars (61)
Biotechnology (5)
Bladder cancer (26)
Brain cancer (5)
Breast cancer (50)
Cancer (474)
Cardiovascular disease (16)
Career advice (9)
CAR-T (12)
Cell therapy (46)
Cervical cancer (3)
Clinical research (7413)
Collaboration (238)
Compensation (17)
Complete response letters (5)
COVID-19 (197)
C-suite (60)
Cystic fibrosis (6)
Data (566)
Depression (11)
Diabetes (30)
Diagnostics (619)
Digital health (4)
Drug discovery (34)
Drug pricing (1)
Duchenne muscular dystrophy (29)
Earnings (7953)
Events (7362)
Executive appointments (63)
FDA (2174)
Fibrodysplasia Ossificans Progressiva (1)
Funding (118)
Gene editing (5)
Generative AI (1)
Gene therapy (29)
GLP-1 (65)
Government (235)
Grass and pollen (1)
Guidances (38)
Healthcare (1084)
HIV (1)
Huntington's disease (2)
IgA nephropathy (18)
Immunology and inflammation (6)
Immuno-oncology (4)
Indications (7)
Infectious disease (211)
Inflammatory bowel disease (23)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (32)
IPO (1647)
Job creations (241)
Job search strategy (9)
JPM (3)
Layoffs (9)
Legal (953)
Liver cancer (18)
Lung cancer (88)
Lymphoma (35)
Machine learning (1)
Manufacturing (80)
MASH (11)
Medical device (1153)
Medtech (1160)
Mergers & acquisitions (3077)
Metabolic disorders (72)
Multiple sclerosis (14)
NASH (1)
Neurodegenerative disease (25)
Neuropsychiatric disorders (5)
Neuroscience (262)
NextGen: Class of 2026 (224)
Non-profit (64)
Obesity (25)
Opinion (2)
Ovarian cancer (21)
Pain (9)
Pancreatic cancer (15)
Parkinson's disease (32)
Partnered (3)
Patents (50)
Patient recruitment (45)
Peanut (1)
People (5108)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase I (2002)
Phase II (3121)
Phase III (2812)
Pipeline (529)
Policy (2)
Postmarket research (241)
Preclinical (693)
Press Release (2)
Prostate cancer (19)
Psychedelics (1)
Radiopharmaceuticals (22)
Rare diseases (53)
Real estate (610)
Regulatory (2852)
Reports (6)
Research institute (98)
RNA editing (2)
RSV (2)
Schizophrenia (16)
Series A (23)
Series B (20)
Service/supplier (1)
Sickle cell disease (5)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (430)
Stomach cancer (1)
Supply chain (12)
The Weekly (1)
Vaccines (39)
Venture capital (5)
Weight loss (6)
Women's health (4)
Date
Today (10)
Last 7 days (41)
Last 30 days (220)
Last 365 days (2728)
2026 (209)
2025 (2692)
2024 (3279)
2023 (3843)
2022 (7047)
2021 (6405)
2020 (5879)
2019 (3875)
2018 (3019)
2017 (3565)
2016 (3171)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (88)
Alabama (3)
Arizona (11)
Asia (21954)
Australia (2459)
California (638)
Canada (365)
China (357)
Colorado (5)
Connecticut (23)
Delaware (6)
Europe (13100)
Florida (58)
Georgia (13)
Illinois (30)
India (33)
Indiana (13)
Japan (232)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (103)
Massachusetts (481)
Michigan (5)
Minnesota (34)
Missouri (3)
Nebraska (2)
Nevada (9)
New Hampshire (1)
New Jersey (366)
New York (219)
North Carolina (89)
Northern California (270)
Ohio (3)
Oregon (1)
Pennsylvania (106)
Rhode Island (1)
South America (108)
Southern California (299)
Tennessee (1)
Texas (52)
United States (2359)
Utah (29)
Virginia (43)
Washington D.C. (3)
Washington State (45)
Wisconsin (7)
72,139 Results for "exscientia ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Exscientia to Present at Upcoming Investor Conferences in June
Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in the following upcoming investor conferences in June.
May 30, 2024
·
1 min read
Business
Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme
Exscientia plc announced that Sanofi is adding a new discovery stage programme identified and initially advanced by Exscientia into the current collaboration.
December 21, 2023
·
3 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Press Releases
Faron Pharmaceuticals Ltd: Appointment of CFO
December 1, 2025
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Business
Exscientia to Report First Quarter 2024 Financial Results on May 21, 2024
Exscientia plc (Nasdaq: EXAI) will report financial results for the first quarter ended March 31, 2024, on Tuesday, May 21, 2024, before the open of U.S. markets.
May 14, 2024
·
1 min read
Press Releases
HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer
March 13, 2025
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile
January 22, 2026
·
13 min read
Exscientia to Present at Upcoming Investor Conferences in March - February 28, 2024
Exscientia plc (Nasdaq: EXAI) today announced that members of management will participate in the following upcoming investor conferences in March.
February 28, 2024
·
1 min read
Business
Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology
Exscientia plc (Nasdaq: EXAI) today announced the appointment of two technology and clinical development leaders to senior roles to significantly strengthen the impact of differentiating technology applications as well as focused oncology pipeline development.
June 6, 2024
·
6 min read
1 of 7,214
Next
